These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27797833)

  • 1. Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse.
    Martin HGS; Lassalle O; Manzoni OJ
    Cereb Cortex; 2017 Dec; 27(12):5592-5602. PubMed ID: 27797833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome.
    Martin HGS; Lassalle O; Brown JT; Manzoni OJ
    Cereb Cortex; 2016 May; 26(5):2084-2092. PubMed ID: 25750254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.
    Costa L; Spatuzza M; D'Antoni S; Bonaccorso CM; Trovato C; Musumeci SA; Leopoldo M; Lacivita E; Catania MV; Ciranna L
    Biol Psychiatry; 2012 Dec; 72(11):924-33. PubMed ID: 22817866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of mGlu
    Manduca A; Bara A; Larrieu T; Lassalle O; Joffre C; Layé S; Manzoni OJ
    J Neurosci; 2017 Jul; 37(29):6851-6868. PubMed ID: 28630250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome.
    Tang AH; Alger BE
    J Neurosci; 2015 Mar; 35(9):3938-45. PubMed ID: 25740522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
    Nosyreva ED; Huber KM
    J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.
    Stoppel LJ; Auerbach BD; Senter RK; Preza AR; Lefkowitz RJ; Bear MF
    Cell Rep; 2017 Mar; 18(12):2807-2814. PubMed ID: 28329674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.
    Zhang J; Hou L; Klann E; Nelson DL
    J Neurophysiol; 2009 May; 101(5):2572-80. PubMed ID: 19244359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.
    Di Menna L; Orlando R; D'Errico G; Ginerete RP; Machaczka A; Bonaccorso CM; Arena A; Spatuzza M; Celli R; Alborghetti M; Ciocca E; Zuena AR; Scioli M; Bruno V; Battaglia G; Nicoletti F; Catania MV
    Neuropharmacology; 2023 Nov; 238():109642. PubMed ID: 37392820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- and Pathway-Specific Disruptions in the Accumbens of Fragile X Mouse.
    Giua G; Pereira-Silva J; Caceres-Rodriguez A; Lassalle O; Chavis P; Manzoni OJ
    J Neurosci; 2024 Jul; 44(30):. PubMed ID: 38830765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
    Lafourcade M; Elezgarai I; Mato S; Bakiri Y; Grandes P; Manzoni OJ
    PLoS One; 2007 Aug; 2(8):e709. PubMed ID: 17684555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying prelimbic prefrontal cortex mGlu
    Joffe ME; Santiago CI; Stansley BJ; Maksymetz J; Gogliotti RG; Engers JL; Nicoletti F; Lindsley CW; Conn PJ
    Neuropharmacology; 2019 Jan; 144():19-28. PubMed ID: 30326237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
    Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
    J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.
    Jung KM; Sepers M; Henstridge CM; Lassalle O; Neuhofer D; Martin H; Ginger M; Frick A; DiPatrizio NV; Mackie K; Katona I; Piomelli D; Manzoni OJ
    Nat Commun; 2012; 3():1080. PubMed ID: 23011134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.
    Gross C; Raj N; Molinaro G; Allen AG; Whyte AJ; Gibson JR; Huber KM; Gourley SL; Bassell GJ
    Cell Rep; 2015 May; 11(5):681-8. PubMed ID: 25921527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
    Michalon A; Sidorov M; Ballard TM; Ozmen L; Spooren W; Wettstein JG; Jaeschke G; Bear MF; Lindemann L
    Neuron; 2012 Apr; 74(1):49-56. PubMed ID: 22500629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.